Carol B Bolden

Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata

S. Lockhart, C. Pham, Carol B Bolden, 2013, Journal of Clinical Microbiology.

Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility.

S. Lockhart, Carol B Bolden, R. Worhle, 2012, Diagnostic microbiology and infectious disease.

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

L. Harrison, S. Lockhart, M. Farley, 2012, Journal of Clinical Microbiology.

Validation of 24-Hour Flucytosine MIC Determination by Comparison with 48-Hour Determination by the Clinical and Laboratory Standards Institute M27-A3 Broth Microdilution Reference Method

S. Lockhart, Carol B Bolden, R. Kuykendall, 2011, Journal of Clinical Microbiology.

The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii

E. Garvey, E. Ottinger, S. Lockhart, 2016, Antimicrobial Agents and Chemotherapy.

Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

W. Schaffner, Z. Beldavs, L. Harrison, 2014, Antimicrobial Agents and Chemotherapy.

Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.

S. Lockhart, C. Pham, Carol B Bolden, 2016, Diagnostic microbiology and infectious disease.

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

L. Harrison, S. Lockhart, M. Farley, 2012, Journal of Clinical Microbiology.